Using difficulty resuming sleep to define nocturnal awakenings.

PubWeight™: 1.73‹?› | Rank: Top 3%

🔗 View Article (PMC 2830306)

Published in Sleep Med on January 13, 2010

Authors

Maurice M Ohayon1, Andrew Krystal, Timothy A Roehrs, Thomas Roth, Michael V Vitiello

Author Affiliations

1: Stanford Sleep Epidemiology Research Center, Stanford University School of Medicine, Stanford, CA 94303, USA. mohayon@stanford.edu

Articles citing this

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep (2011) 0.99

Hierarchy of insomnia criteria based on daytime consequences. Sleep Med (2011) 0.94

Prospective assessment of nocturnal awakenings in a case series of treatment-seeking chronic insomnia patients: a pilot study of subjective and objective causes. Sleep (2012) 0.88

Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use. Sleep (2014) 0.88

Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study. Sleep (2013) 0.80

Diagnostic and Statistical Manual criteria for insomnia related impairment in daytime functioning: polysomnographic correlates in older adults. Sleep Med (2012) 0.78

Frequent nocturnal awakening in children: prevalence, risk factors, and associations with subjective sleep perception and daytime sleepiness. BMC Psychiatry (2014) 0.77

Cataloging nocturia (circa 2014). Sleep (2014) 0.75

The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study
. Cerebrovasc Dis Extra (2017) 0.75

Peeling the artichoke. Sleep Med (2010) 0.75

Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health (2016) 0.75

Articles by these authors

Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep (2004) 10.08

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep (2003) 4.29

History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22

Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78

Sleep loss and REM sleep loss are hyperalgesic. Sleep (2006) 3.03

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol (2012) 3.01

Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res (2002) 2.99

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86

The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res (2006) 2.60

Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med (2005) 2.51

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res (2002) 2.48

Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep (2007) 2.43

Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc (2009) 2.34

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology (2008) 2.31

Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 2.19

Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13

Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics (2006) 2.06

Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep (2007) 2.05

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep (2008) 2.04

Sleep disturbance in menopause. Menopause (2007) 1.94

Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation '2003 Sleep in America' Poll. Am J Geriatr Psychiatry (2007) 1.88

The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med (2005) 1.87

The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep (2003) 1.86

Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep (2004) 1.84

Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance. Menopause (2006) 1.84

Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83

Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77

Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev (2001) 1.75

Factors associated with caregiver reports of sleep disturbances in persons with dementia. Am J Geriatr Psychiatry (2006) 1.74

Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev (2011) 1.74

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72

Effects of moderate-intensity exercise on polysomnographic and subjective sleep quality in older adults with mild to moderate sleep complaints. J Gerontol A Biol Sci Med Sci (2008) 1.67

Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc (2005) 1.57

Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety (2003) 1.54

Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry (2008) 1.51

Sleep disturbances in caregivers of persons with dementia: contributing factors and treatment implications. Sleep Med Rev (2007) 1.49

A twin study of sleep duration and body mass index. J Clin Sleep Med (2010) 1.48

Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol (2005) 1.48

Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J Psychosom Res (2005) 1.47

Sleep in dementia. Am J Geriatr Psychiatry (2006) 1.47

Nocturia and disturbed sleep in the elderly. Sleep Med (2008) 1.47

Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med (2013) 1.43

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med (2005) 1.42

Caffeine: sleep and daytime sleepiness. Sleep Med Rev (2007) 1.41

Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38

Sleep during titration predicts continuous positive airway pressure compliance. Sleep (2003) 1.37

Sleep and pain: interaction of two vital functions. Semin Neurol (2005) 1.37

Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35

Evidence-based psychological treatments for insomnia in older adults. Psychol Aging (2007) 1.35

Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. J Am Geriatr Soc (2011) 1.32

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin (2004) 1.29

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28

Sleep hygiene practices in a population-based sample of insomniacs. Sleep (2005) 1.26

The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep (2010) 1.25

Lack of sleep disturbance from menopausal hot flashes. Fertil Steril (2004) 1.24

Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med (2011) 1.24

Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep (2003) 1.23

Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med (2010) 1.22

Growing old should not mean sleeping poorly: recognizing and properly treating sleep disorders in older adults. J Am Geriatr Soc (2007) 1.21

Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol (2003) 1.20

Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19

A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev (2007) 1.19

Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep (2003) 1.17

Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med (2007) 1.17

The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep (2006) 1.17

Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics (2006) 1.16

Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16

Shift work sleep disorder: burden of illness and approaches to management. Drugs (2006) 1.15

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry (2008) 1.15

A pilot study of gentle yoga for sleep disturbance in women with osteoarthritis. Sleep Med (2011) 1.14

Zolpidem for insomnia. Expert Opin Pharmacother (2012) 1.14

Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep (2008) 1.13

MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep (2011) 1.13

Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry (2010) 1.13

Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry (2008) 1.12

Naps, cognition and performance. Sleep Med Rev (2009) 1.12

Sleep duration and body mass index in twins: a gene-environment interaction. Sleep (2012) 1.11

Digital analysis and technical specifications. J Clin Sleep Med (2007) 1.11

The Acute Hangover Scale: A new measure of immediate hangover symptoms. Addict Behav (2006) 1.09

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol (2006) 1.09

Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol (2002) 1.09

Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. Sleep (2010) 1.08

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul (2010) 1.07

The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry (2012) 1.07

Consequences of shiftworking on sleep duration, sleepiness, and sleep attacks. Chronobiol Int (2010) 1.07

Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Med (2006) 1.06

Factors associated with concordance and variability of sleep quality in persons with Alzheimer's disease and their caregivers. Sleep (2008) 1.06

Insomnia pharmacotherapy. Neurotherapeutics (2012) 1.05

Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? Sleep (2006) 1.04

Sleep reactivity and insomnia: genetic and environmental influences. Sleep (2011) 1.03

Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurol (2013) 1.02

Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath (2007) 1.02

Pain sensitivity in sleepy pain-free normals. Sleep (2009) 1.02